| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |